Articles
View all articles-
'New drug policy to negatively impact investment in pharmas'
"At a company level, we were aware of the upcoming policy and have factored in the impact which is likely to be in the range of 3-4 per cent of our finished dosage sales in India. We have plans in place to ride over this impact," Dr Reddy's Laboratories Vice-Chairman and MD Satish Reddy said. #Pharmaceuticals in India #WhoSaidWhat #Dr. Reddy's Laboratories #drug policy
-
Sun Pharma ends deal to take over Taro
The companies decided that ending the deal was in the best interest of their shareholders, Sun Pharma and Taro said in a joint filing. #DealStream #Sun Pharma #Taro Pharmaceutical Industries
-
Prosecution likely in Rs 700 crore case, time for Asaram Bapu to say his mantras?
The godman's trust has been accused of grabbing property worth Rs 700 crore that belongs to a pharmaceutical company. #NewsTracker #Serious Fraud Investigation Office #Land-Grab #Asaram Bapu #Pharmaceutical company
Blog posts
View all blog posts-
Issue of antibiotic resistance concerns us all, why are we so lax?
Anti-microbial resistance is a public health hazard which needs to be tackled with urgency. But the ministry is busy with bureaucratic solutions to scientific problems. #HowThisWorks #Medicine #Pharmaceutical industry #Antibiotics
-
Breakthrough in AIDS battle: How relevant for India?
The new study on HIV/AIDS, which said treating infected people with anti-retrovirals early on could stop infection transmission, sounds promising. However, early detection and the course of medication are still huge challenges. #HIV/AIDS #Health/Medical/Pharmaceuticals #Duesberg hypothesis #HIV
Wire
-
Economic Times
India-China ink 3 MoUs including pharmaceuticals
NEW DELHI: India and China on Monday signed three agreements on areas including buffalo meat and pharmaceuticals, a move which will help in bridging the widening trade deficit. "These Memorandum of Understandings (MoUs) will address the growing trade def #India #China #New Delhi
-
InPharmaTechnologist
People on the Move: Pharma Jobs
First up this week is Bayer who has announced Dr. Herbert Heitmann will head the newly created Communications and Government Relations unit from September. Heitmann is currently Executive Vice President of External Communications at Royal Dutch Shell and #Bayer 04 Leverkusen #Royal Dutch Shell #Cambodia
-
CNBC
Actavis to Buy Warner Chilcott
Generic drugmaker Actavis, which has been the subject of intense takeover speculation, said on Monday that it had struck a deal to buy specialty pharmaceuticals company for $8.5 billion in stock. The move comes as Actavis has spurned approaches from Cana #Warner Chilcott Limited #CNBC #Commodity Futures Trading Commission




